PDB9 IMPACT OF FDA SAFETY WARNINGS ON SUBSEQUENT DIABETES CARE FOR USERS OF ROSIGLITAZONE
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74987-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)74987-1/fulltext
Title :
PDB9 IMPACT OF FDA SAFETY WARNINGS ON SUBSEQUENT DIABETES CARE FOR USERS OF ROSIGLITAZONE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74987-1&doi=10.1016/S1098-3015(10)74987-1
First page :
Section Title :
Open access? :
No
Section Order :
911